Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys

被引：0
|
作者：
Sola, MC
Christensen, RD
Hutson, AD
Tarantal, AF
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Calif Reg Primate Res Ctr, Davis, CA USA
来源：
PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期
关键词：
D O I：
10.1203/00006450-199904020-01575
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1558
引用
收藏
页码：265A / 265A
页数：1
相关论文
共 50 条
  • [31] Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
    Hou, Ling
    Chen, Zhi-hang
    Liu, Dong
    Cheng, Yuan-guo
    Luo, Xiao-ping
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 13 - 21
  • [32] Recombinant human megakaryocyte growth and development factor attenuates postbypass thrombocytopenia
    Nakamura, M
    Toombs, CF
    Duarte, IG
    Ronson, RS
    Schmarkey, IS
    Katzmark, SL
    Robinson, J
    Dillehay, DL
    Vinten-Johansen, J
    Guyton, RA
    ANNALS OF THORACIC SURGERY, 1998, 66 (04): : 1216 - 1223
  • [33] Biological effect of pegylated recombinant megakaryocyte growth and development factor (PEG-MGDF) in patients with idiopathic thrombocytopenic purpura.
    Dan, K
    Nomura, S
    Hotta, T
    Fujimura, K
    Ikeda, Y
    BLOOD, 2001, 98 (11) : 299A - 299A
  • [34] Effects of recombinant human megakaryocyte growth and development factor on platelet activation
    Montrucchio, G
    Brizzi, MF
    Calosso, G
    Marengo, S
    Pegoraro, L
    Camussi, G
    BLOOD, 1996, 87 (07) : 2762 - 2768
  • [35] Recombinant megakaryocyte growth and development factor - Biology and potential clinical applications
    Barge, AJ
    PLATELETS, 1997, 8 (06) : 446 - 446
  • [36] Pegylated recombinant human megakaryocyte growth and development factor synergizes with recombinant human granulocyte colony stimulating factor to expand hematopoietic stem cells in vivo in mice.
    Akahori, H
    Tawara, T
    Sawa, Y
    Ida, M
    Ozai, M
    Kato, T
    Miyazaki, H
    BLOOD, 1998, 92 (10) : 111A - 111A
  • [37] Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome
    Kizaki, M
    Miyakawa, Y
    Ikeda, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (05) : 764 - 767
  • [38] Effects of pegylated recombinant human megakaryocyte growth and development factor on 5-fluorouracil-induced thrombocytopenia in balloon-injured rats
    Harada, K
    Tazunoki, Y
    Ide, Y
    Takeuchi, A
    Kawahara, J
    Suzuki, T
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (03) : 321 - 325
  • [39] Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation
    OMalley, CJ
    Rasko, JEJ
    Basser, RL
    McGrath, KM
    Cebon, J
    Grigg, AP
    Hopkins, W
    Cohen, B
    OByrne, J
    Green, MD
    Fox, RM
    Berndt, MC
    Begley, CG
    BLOOD, 1996, 88 (09) : 3288 - 3298
  • [40] Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia:: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors
    Yin, JAL
    Adams, JA
    Brereton, ML
    Hann, A
    Harrison, BD
    Briggs, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 743 - 746
12345